Analysts Set Goldman Sachs BDC Inc (NYSE:GSBD) Price Target at $21.25

Share on StockTwits

Goldman Sachs BDC Inc (NYSE:GSBD) has been given an average rating of “Hold” by the eight research firms that are covering the company, Marketbeat reports. Four research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $21.25.

A number of research firms recently weighed in on GSBD. Zacks Investment Research raised shares of Goldman Sachs BDC from a “strong sell” rating to a “hold” rating in a report on Friday, May 10th. National Securities reaffirmed a “buy” rating and set a $22.00 price target on shares of Goldman Sachs BDC in a report on Monday, May 13th. Wells Fargo & Co reaffirmed a “market perform” rating and set a $20.00 price target (down from $20.50) on shares of Goldman Sachs BDC in a report on Monday, May 13th. Citigroup reduced their price objective on shares of Goldman Sachs BDC from $23.00 to $21.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 17th. Finally, Raymond James reduced their price objective on shares of Goldman Sachs BDC from $24.00 to $23.00 and set a “strong-buy” rating on the stock in a research note on Monday, March 4th.

A number of hedge funds and other institutional investors have recently bought and sold shares of GSBD. Azimuth Capital Management LLC boosted its stake in Goldman Sachs BDC by 86.0% during the 1st quarter. Azimuth Capital Management LLC now owns 142,995 shares of the financial services provider’s stock valued at $2,937,000 after acquiring an additional 66,135 shares during the last quarter. Cetera Advisor Networks LLC lifted its position in shares of Goldman Sachs BDC by 372.8% in the 4th quarter. Cetera Advisor Networks LLC now owns 60,148 shares of the financial services provider’s stock worth $1,100,000 after buying an additional 47,426 shares during the last quarter. Greenwich Investment Management Inc. lifted its position in shares of Goldman Sachs BDC by 72.0% in the 4th quarter. Greenwich Investment Management Inc. now owns 79,425 shares of the financial services provider’s stock worth $1,460,000 after buying an additional 33,235 shares during the last quarter. Legal & General Group Plc lifted its position in shares of Goldman Sachs BDC by 13.7% in the 4th quarter. Legal & General Group Plc now owns 185,581 shares of the financial services provider’s stock worth $3,417,000 after buying an additional 22,375 shares during the last quarter. Finally, Raymond James Financial Services Advisors Inc. lifted its position in shares of Goldman Sachs BDC by 94.5% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 42,175 shares of the financial services provider’s stock worth $866,000 after buying an additional 20,488 shares during the last quarter. Hedge funds and other institutional investors own 34.88% of the company’s stock.

GSBD traded down $0.06 during trading hours on Friday, reaching $19.89. 4,907 shares of the stock traded hands, compared to its average volume of 164,836. The business’s fifty day moving average price is $19.86. The firm has a market cap of $803.99 million, a P/E ratio of 9.67, a price-to-earnings-growth ratio of 10.10 and a beta of 0.98. Goldman Sachs BDC has a fifty-two week low of $17.73 and a fifty-two week high of $22.75. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 1.01.

Goldman Sachs BDC (NYSE:GSBD) last released its quarterly earnings results on Thursday, May 9th. The financial services provider reported $0.55 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.48 by $0.07. The business had revenue of $36.54 million during the quarter, compared to analyst estimates of $36.22 million. Goldman Sachs BDC had a net margin of 25.34% and a return on equity of 12.08%. The business’s revenue was up 2.8% on a year-over-year basis. During the same period last year, the business earned $0.46 EPS. Analysts predict that Goldman Sachs BDC will post 1.99 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Friday, June 28th will be paid a dividend of $0.45 per share. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $1.80 dividend on an annualized basis and a yield of 9.05%. Goldman Sachs BDC’s dividend payout ratio (DPR) is 87.38%.

About Goldman Sachs BDC

Goldman Sachs BDC, Inc is a business development company specializing in middle market and mezzanine investment in private companies. It seeks to make capital appreciation through direct originations of secured debt, senior secured debt, junior secured debt, including first lien, first lien/last-out unitranche and second lien debt, unsecured debt, including mezzanine debt and, to a lesser extent, investments in equities.

Further Reading: Green Investing

Analyst Recommendations for Goldman Sachs BDC (NYSE:GSBD)

Receive News & Ratings for Goldman Sachs BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Goldman Sachs BDC and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Brokerages Expect Coeur Mining Inc  Will Post Earnings of -$0.07 Per Share
Brokerages Expect Coeur Mining Inc Will Post Earnings of -$0.07 Per Share
-$0.12 Earnings Per Share Expected for Ferroglobe PLC  This Quarter
-$0.12 Earnings Per Share Expected for Ferroglobe PLC This Quarter
Brokerages Anticipate Eastside Distilling Inc  Will Announce Earnings of -$0.19 Per Share
Brokerages Anticipate Eastside Distilling Inc Will Announce Earnings of -$0.19 Per Share
Nanometrics Incorporated  Expected to Announce Earnings of $0.21 Per Share
Nanometrics Incorporated Expected to Announce Earnings of $0.21 Per Share
-$0.08 Earnings Per Share Expected for ZIOPHARM Oncology Inc.  This Quarter
-$0.08 Earnings Per Share Expected for ZIOPHARM Oncology Inc. This Quarter
Short Interest in Unifi, Inc.  Drops By 7.6%
Short Interest in Unifi, Inc. Drops By 7.6%


© 2006-2019 Ticker Report